Division of Neurology and Department of Epidemiology & Biostatistics, Western University, London, Ontario, Canada.
Department of Neurology, McMaster University, Hamilton, Ontario, Canada.
Cerebrovasc Dis. 2021;50(6):622-635. doi: 10.1159/000515829. Epub 2021 May 27.
Combining available therapies has the potential to reduce the risk of stroke by 80% or more. A comprehensive review of all aspects of stroke prevention would be very lengthy; in this narrative review, we focus on some aspects of stroke prevention that are little-known and/or neglected. These include the following: (1) implementation of a Mediterranean diet; (2) B vitamins to lower homocysteine; (3) coordinated approaches to smoking cessation; (4) intensive lipid-lowering therapy; (5) lipid lowering in the elderly; (6) physiologically individualized therapy for hypertension based on renin/aldosterone phenotyping; (7) avoiding excessive blood pressure reduction in patients with stiff arteries; (8) treatment of insulin resistance with pioglitazone in stroke patients with prediabetes and diabetes; (9) impaired activation of clopidogrel in patients with variants of CYP2C19; (10) aspirin pseudoresistance due to enteric coating; (11) rationale for anticoagulation in patients with embolic stroke of unknown source; (12) pharmacologic properties of direct-acting oral anticoagulants that should be considered when choosing among them; (13) the identification of which patients with asymptomatic carotid stenosis are at a high enough risk to benefit from carotid endarterectomy or stenting; and (14) the importance of age in choosing between endarterectomy and stenting. Stroke prevention could be improved by better recognition of these issues and by implementation of the principles derived from them.
联合应用现有疗法有可能将中风风险降低 80%以上。对中风预防的各个方面进行全面审查将非常冗长;在本叙述性综述中,我们重点关注一些鲜为人知和/或被忽视的中风预防方面。这些方面包括:(1)实施地中海饮食;(2)B 族维生素降低同型半胱氨酸;(3)协调戒烟方法;(4)强化降脂治疗;(5)老年人降脂;(6)基于肾素/醛固酮表型对高血压进行生理个体化治疗;(7)避免动脉硬化患者血压过度降低;(8)在伴有糖尿病前期和糖尿病的中风患者中使用吡格列酮治疗胰岛素抵抗;(9)CYP2C19 变体患者中氯吡格雷的激活受损;(10)肠溶包衣导致的阿司匹林假性抵抗;(11)不明原因栓塞性中风患者抗凝治疗的理由;(12)在选择直接作用口服抗凝剂时应考虑的药物特性;(13)确定哪些无症状颈动脉狭窄患者的风险足够高,可从颈动脉内膜切除术或支架置入术获益;以及(14)年龄在选择内膜切除术和支架置入术之间的重要性。通过更好地认识这些问题并实施从中得出的原则,可以改善中风预防。